stars 1 stars 2 stars 3

Ethypharm is a leading mid-size international pharmaceutical company, with strong European roots, that manufactures and provides essential medicines, with a focus on Hospital Injectables, Central Nervous System (severe pain and addiction). Our commitment is to improve patients' lives and make a positive impact on society and the environment. Ethypharm has 1,800 employees dedicated to its various pharmaceutical activities, of which 1400 are in industrial operations. Our six production sites located in France, the UK, Spain, and China have expertise in injectables and complex oral solid forms. With a global presence in 68 countries, the company markets its products directly in Europe and China, and has strategic partnerships in the EMEA, NA, LATAM and APAC markets. Ethypharm works closely with the authorities and healthcare professionals to ensure that its medicines are used appropriately and that patients have access to them. To find out more about Ethypharm, visit http://www.ethypharm.com and follow us on LinkedIn.

Ethypharm Questions

The Ethypharm annual revenue was $406 million in 2026.

Frédéric Molin is the EVP Corporate Development of Ethypharm.

769 people are employed at Ethypharm.

Ethypharm is based in Saint-Cloud, Ile-de-France.

The NAICS codes for Ethypharm are [3254, 325, 32541, 32].

The SIC codes for Ethypharm are [283, 28].

Top Ethypharm Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users